Human genetic diversity in today’s world has been shaped by evolutionary history, demographic shifts and environmental exposures, influencing complex traits, disease susceptibility and drug responses. Capturing this diversity is essential for advancing precision medicine and promoting equitable healthcare. Despite the great progress achieved with initiatives such as the human Pangenome and large biobanks that aim for a better representation of human diversity, important challenges remain. In this Perspective, we discuss the importance of diversity in clinical genomics through an evolutionary lens. We highlight progress and challenges and outline key clinical applications of diverse genetic data. We argue that diversifying both datasets and methodologies—integrating ancestral and environmental factors—is crucial for fully understanding the genetic basis of human health and disease.
Traditional clustering and visualization approaches in human genetics often operate under frameworks that assume inherent, discrete groupings 1,2 . These methods can inadvertently simplify multifaceted relationships, functioning to entrench the idea of typological groups 3 . We introduce a network-based pipeline and visualization tool grounded in relational thinking 4 , which constructs networks from a variety of genetic similarity metrics. We identify communities at multiple resolutions, departing from typological models of analysis and interpretation that categorize individuals into a (predefined) number of sets. We applied our pipeline to a dataset merged from the 1000 Genomes and Human Genome Diversity Project 5 , revealing the limitations of traditional groupings and capturing the complexities introduced by demographic events and evolutionary processes. This method embraces the context-specificity of genetic similarities that are salient depending on the question, markers of interest, and study individuals. Different numbers of communities are revealed depending on the resolution chosen and metric used, underscoring a fluid spectrum of genetic relationships and challenging the notion of universal categorization. We provide a web application ( https://sohail-lab.shinyapps.io/GG-NC/ ) for interactive visualization and engagement with these intricate genetic landscapes.
Introduction. Despite the pressing need for robust data to guide mental health and addiction strategies in Mexico, few studies have systematically analyzed patient profiles and diagnostic patterns in specialized centers. This study addresses that gap by performing a retrospective, cross-sectional, descriptive analysis of the records of the Temazcalli Institute for Prevention and Rehabilitation. Objective. To describe the sociodemographic variables and primary diagnoses of patients treated for addictions and mental health disorders at the Temazcalli Institute between January 2021 and May 2024. Method. A retrospective, cross-sectional, descriptive study was conducted using 1,520 outpatient records and 432 first-time diagnoses, analyzed in R (v4.3). Mann-Whitney U test, Spearman correlations, and frequency analyses were applied to explore associations between age, sex, and number of diagnoses. Results: The research sample was predominantly male (64.1%), with a median age of 18 years, with 79.3% aged 30 or less. The mean number of diagnoses per patient was 2.6 (SD = 1.4) and showed a positive correlation with age (ρ = .31; p < .001). The most common diagnoses included ADHD (23.8%), cannabis use disorder (16.2%), and stimulant use disorder (16.0%). Discussion and conclusion. These findings provide essential evidence to inform the design of targeted preventive interventions at Temazcalli and similar centers. The results underscore the importance of early, youth-focused strategies and integrated clinical and policy approaches to address mental health and addiction issues.